Home > News > Nanoparticle delivery method of insulin gene to combat juvenile diabetes
June 1st, 2007
Nanoparticle delivery method of insulin gene to combat juvenile diabetes
A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented today at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
Type 1 or juvenile diabetes is caused by autoimmune destruction of the insulin producing pancreatic β-cells. As a result of the loss of insulin, blood sugar levels rise too high, causing damage to fine blood vessels and nerve endings leading to debilitating symptoms. As a result patients become dependent upon daily insulin injections to survive. However, it is virtually impossible to match the sugar content of each meal with the optimal dose of insulin - the cumulative ‘mistakes' severely reduce both the quality and length of life.
Made-in-Singapore rapid test kit detects dengue antibodies from saliva: IBN's MedTech innovation simplifies diagnosis of infectious diseases January 29th, 2015
Iranian Researchers Planning to Produce Edible Insulin January 28th, 2015
Nanoparticles that deliver oligonucleotide drugs into cells described in Nucleic Acid Therapeutics January 28th, 2015
Nanoliposomes Help Efforts to Cure Bacterial Infections January 27th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Discovery Channel taps Angstron Materials for segment featuring graphene advances January 29th, 2015
Asteroid Mining 101: A New Book by World-Renowned Expert Dr. John S. Lewis - Exclusive Sneak-Peek Opportunity for Book Reviewers and Media January 29th, 2015
Los Alamos Develops New Technique for Growing High-Efficiency Perovskite Solar Cells: Researchers’ crystal-production insights resolve manufacturing difficulty January 29th, 2015
Iranian Scientists Use MOFs to Eliminate Dye Pollutants January 29th, 2015